Recently, it has been demonstrated that tumoral TGF-β signaling has a role in promoting bone metastatic progression and osteolysis in ER+ breast cancer through stimulating the secretion of osteolytic factors such as PTHrP [114]. This evidence concerns the gene TGFB1 and breast carcinoma.